Glycemic Index of Mango and Pear in Different Solid Products and Drinks

NCT ID: NCT01929551

Last Updated: 2014-09-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-08-31

Study Completion Date

2013-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the glycemic index of a beverage made of natural concentrated mango puree with natural concentrated pear juice with other five different products based on natural mango and pear ingredients in the form of fruit or juice against a control of 50-gram glucose load.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The participants will be recruited with an open invitation to participate, those who voluntarily accept, sign an informed consent, and meet the all inclusion criteria and none of the exclusion criteria will participate.

Each participant will receive a different product (of the seven products available) each day of the test (8 days in total), making sure everyone receives each one of the products. All products will be distributed in a randomized fashion for each of the participants. The 50-gram glucose load (gold standard) will be the reference or control, and will be taken twice by each subject in the test.

Each one of the products given will contain 50 grams of carbohydrate. The time given to consume the products will be 10 minutes total.

There will be a "wash out" period of three days in between each product.

The participants will eat the product and capillary glucose will be taken with a glucometer (Accu-Chek Performa System © 2009 Roche Diagnostics. Roche Products, México) at times: 0, 15, 30, 45, 60, 75, 90, 150 and 120 minutes. The glucometer will be calibrated with a standard glucose solution every day previous to the test. The results will be used to calculate the glycemic index. At the end of the 120 minutes, the participants will receive a questionnaire of digestive symptoms presented during the test.

The glycemic index will be calculated by the area under the curve for each product divided by the area under the curve for the 50-gram glucose load, multiplied by 100. The area under the curve used to calculate the glycemic index is the area that surpasses the basal line, excluding the area under the basal line according to the Food and Agriculture Organization (FAO) in 1998 (Brouns et al 2005).

All information collected will be emptied into a pre-designed database.

The differences between the different products ingested will be analyzed with the statistical test of analysis of variance (ANOVA) with a pre-test of homogeneity of variance Brown-Foryhte. In case of failure to find homogeneity in the variances the nonparametric ANOVA, the Kruskal-Wallis test, will be used. The results will be expressed as mean ± standard deviation for each with a significance level of 0.05 for all the statistical tests.

After ANOVA, Tuckey Multiple Comparisons test will be used to evaluate the pairwise relationship for each product.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glucose Intolerance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mango puree and pear juice beverage

Participants will drink 450 milliliters of the juice at time 0.

Group Type OTHER

Mango puree and pear juice beverage

Intervention Type OTHER

Capillary glucose will be taken every 15 minutes for two hours (starting at time 0) to calculate the area under the curve which is the glycemic index, for each of the products.

Commercial mango juice

Participants will drink 450 milliliters of the juice at time 0.

Group Type OTHER

Commercial mango juice

Intervention Type OTHER

Capillary glucose will be taken every 15 minutes for two hours (starting at time 0) to calculate the area under the curve which is the glycemic index, for each of the products.

Fresh natural mango

Participants will eat 400 to 500 grams of frozen mango pulp, along with 250 milliliters of water at time 0.

Group Type OTHER

Fresh natural mango

Intervention Type OTHER

Capillary glucose will be taken every 15 minutes for two hours (starting at time 0) to calculate the area under the curve which is the glycemic index, for each of the products.

Frozen natural mango

Participants will eat 400 to 500 grams of frozen mango pulp, along with 250 milliliters of water at time 0.

Group Type OTHER

Frozen natural mango

Intervention Type OTHER

Capillary glucose will be taken every 15 minutes for two hours (starting at time 0) to calculate the area under the curve which is the glycemic index, for each of the products.

Processed natural mango pulp

Participants will eat 400 to 500 grams of frozen mango pulp, along with 250 milliliters of water at time 0.

Group Type OTHER

Processed natural mango pulp

Intervention Type OTHER

Capillary glucose will be taken every 15 minutes for two hours (starting at time 0) to calculate the area under the curve which is the glycemic index, for each of the products.

Mix of natural mango and pear

Participants will eat 400 to 500 grams of a mixture of fresh natural fruit containing mango (73%) and pear (27%), along with 250 milliliters of water at time 0.

Group Type OTHER

Mix of natural mango and pear

Intervention Type OTHER

Capillary glucose will be taken every 15 minutes for two hours (starting at time 0) to calculate the area under the curve which is the glycemic index, for each of the products.

50 grams glucose load

Participants will drink 250 milliliters of the standard glucose load at time 0.

Group Type OTHER

50 grams glucose load

Intervention Type OTHER

Capillary glucose will be taken every 15 minutes for two hours (starting at time 0) to calculate the area under the curve which is the glycemic index, for each of the products.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mango puree and pear juice beverage

Capillary glucose will be taken every 15 minutes for two hours (starting at time 0) to calculate the area under the curve which is the glycemic index, for each of the products.

Intervention Type OTHER

Commercial mango juice

Capillary glucose will be taken every 15 minutes for two hours (starting at time 0) to calculate the area under the curve which is the glycemic index, for each of the products.

Intervention Type OTHER

Fresh natural mango

Capillary glucose will be taken every 15 minutes for two hours (starting at time 0) to calculate the area under the curve which is the glycemic index, for each of the products.

Intervention Type OTHER

Frozen natural mango

Capillary glucose will be taken every 15 minutes for two hours (starting at time 0) to calculate the area under the curve which is the glycemic index, for each of the products.

Intervention Type OTHER

Processed natural mango pulp

Capillary glucose will be taken every 15 minutes for two hours (starting at time 0) to calculate the area under the curve which is the glycemic index, for each of the products.

Intervention Type OTHER

Mix of natural mango and pear

Capillary glucose will be taken every 15 minutes for two hours (starting at time 0) to calculate the area under the curve which is the glycemic index, for each of the products.

Intervention Type OTHER

50 grams glucose load

Capillary glucose will be taken every 15 minutes for two hours (starting at time 0) to calculate the area under the curve which is the glycemic index, for each of the products.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Determination of glycemic index of MPPJB. Determination of glycemic index of commercial mango juice Determination of glycemic index of fresh natural mango Determination of glycemic index of frozen natural mango Determination of glycemic index of PNMP. Determination of glycemic index for mix of NMP. Determination of glycemic index for 50 grams glucose load

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women
* Ages 18 to 50 years
* Body mass index between 18.5 and 27.4 kilograms divided by squared meters
* Waist circumference ≤ 102 centimeters for men and ≤88 centimeters for women
* Fasting capillary glucose ≤100 milligrams per deciliter

The night before the study:

* 10 hours fasting
* Light dinner of their choice and repeat it every time before the study
* No alcohol, coffee or tea drinks the previous night
* No vigorous exercise the day before the test nor the morning of the test

Exclusion Criteria

* Consumption of any of the following: oral hypoglycemic drugs, oral or parenteral glucocorticoid drugs, thyroid hormones, stimulant of intestinal motility or other drugs that may interfere with the intestinal absorption during the test
* Acute or chronic gastrointestinal infections
* Breast feeding or pregnant women
* Intestinal surgeries in the last 6 months
* Allergies to any of the products we will be using
* Subjects with gastrointestinal or metabolic diseases
* Subjects with first grade family history of diabetes mellitus
* Subjects with glucose intolerance, insulin resistance or diabetes mellitus
* Subjects who dislike any of the products we will be using
* Subjects with an acute (previous 24 hours) digestive crisis including: gastritis, diarrhea, and vomit, among others
* Subjects with a history of mal-absorption

Suspension:

* Subjects that do not arrive at the test-day
* Fasting glucose ≥ 100 milligrams per deciliter the day of the test
* Subjects who develop gastrointestinal disease during the study time frame
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Instituto Tecnologico y de Estudios Superiores de Monterey

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Leticia Elizondo-Montemayor

M.D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Leticia Elizondo-Montemayor, MD

Role: PRINCIPAL_INVESTIGATOR

Clinical Nutrition and Obesity Research Center. TEC Salud, School of Medicine and Health Sciences. Instituto Tecnologico y de Estudios Superiores de Monterrey

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinical Nutrition and Obesity Research Center. School of Medicine and Health Sciences, TEC Salud, Tecnológico de Monterrey

Monterrey, Nuevo León, Mexico

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Mexico

References

Explore related publications, articles, or registry entries linked to this study.

Brand JC, Holt S, Saveny and Hanksy J. Plasma glucose correlates inversely with satiety and CCK. Proc Nutr Soc Aust 1990; 15: 209 (abstr).

Reference Type BACKGROUND

Brock DW, Davis CK, Irving BA, Rodriguez J, Barrett EJ, Weltman A, Taylor AG, Gaesser GA. A high-carbohydrate, high-fiber meal improves endothelial function in adults with the metabolic syndrome. Diabetes Care. 2006 Oct;29(10):2313-5. doi: 10.2337/dc06-0917. No abstract available.

Reference Type BACKGROUND
PMID: 17003313 (View on PubMed)

Brouns F, Bjorck I, Frayn KN, Gibbs AL, Lang V, Slama G, Wolever TM. Glycaemic index methodology. Nutr Res Rev. 2005 Jun;18(1):145-71. doi: 10.1079/NRR2005100.

Reference Type BACKGROUND
PMID: 19079901 (View on PubMed)

Carlson JJ, Eisenmann JC, Norman GJ, Ortiz KA, Young PC. Dietary fiber and nutrient density are inversely associated with the metabolic syndrome in US adolescents. J Am Diet Assoc. 2011 Nov;111(11):1688-95. doi: 10.1016/j.jada.2011.08.008.

Reference Type BACKGROUND
PMID: 22027051 (View on PubMed)

Carlson JJ, Monti V. The role of inclusive dietary patterns for achieving secondary prevention cardiovascular nutrition guidelines and optimal cardiovascular health. J Cardiopulm Rehabil. 2003 Sep-Oct;23(5):322-33. doi: 10.1097/00008483-200309000-00001. No abstract available.

Reference Type BACKGROUND
PMID: 14512776 (View on PubMed)

Carlson JJ, Winkleby M, Gardner C, Ahn D. Plant-based food intake and cardiovascular disease (CVD) risk factor status in a national sample of ethnically diverse women (NHANES III) FASEB J. 2003a;17:A372.

Reference Type BACKGROUND

Delzenne NM, Cani PD. A place for dietary fibre in the management of the metabolic syndrome. Curr Opin Clin Nutr Metab Care. 2005 Nov;8(6):636-40. doi: 10.1097/01.mco.0000171124.06408.71.

Reference Type BACKGROUND
PMID: 16205465 (View on PubMed)

Dubnov-Raz G, Berry EM. The dietary treatment of obesity. Endocrinol Metab Clin North Am. 2008 Dec;37(4):873-86. doi: 10.1016/j.ecl.2008.08.002.

Reference Type BACKGROUND
PMID: 19026937 (View on PubMed)

Ellison JM, Stegmann JM, Colner SL, Michael RH, Sharma MK, Ervin KR, Horwitz DL. Rapid changes in postprandial blood glucose produce concentration differences at finger, forearm, and thigh sampling sites. Diabetes Care. 2002 Jun;25(6):961-4. doi: 10.2337/diacare.25.6.961.

Reference Type BACKGROUND
PMID: 12032099 (View on PubMed)

Estruch R, Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Ruiz-Gutierrez V, Covas MI, Fiol M, Gomez-Gracia E, Lopez-Sabater MC, Vinyoles E, Aros F, Conde M, Lahoz C, Lapetra J, Saez G, Ros E; PREDIMED Study Investigators. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 2006 Jul 4;145(1):1-11. doi: 10.7326/0003-4819-145-1-200607040-00004.

Reference Type BACKGROUND
PMID: 16818923 (View on PubMed)

Granfeldt Y, Hagander B, Bjorck I. Metabolic responses to starch in oat and wheat products. On the importance of food structure, incomplete gelatinization or presence of viscous dietary fibre. Eur J Clin Nutr. 1995 Mar;49(3):189-99.

Reference Type BACKGROUND
PMID: 7774535 (View on PubMed)

Halton TL, Willett WC, Liu S, Manson JE, Albert CM, Rexrode K, Hu FB. Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med. 2006 Nov 9;355(19):1991-2002. doi: 10.1056/NEJMoa055317.

Reference Type BACKGROUND
PMID: 17093250 (View on PubMed)

Hatonen KA, Simila ME, Virtamo JR, Eriksson JG, Hannila ML, Sinkko HK, Sundvall JE, Mykkanen HM, Valsta LM. Methodologic considerations in the measurement of glycemic index: glycemic response to rye bread, oatmeal porridge, and mashed potato. Am J Clin Nutr. 2006 Nov;84(5):1055-61. doi: 10.1093/ajcn/84.5.1055.

Reference Type BACKGROUND
PMID: 17093157 (View on PubMed)

Hu FB. Diet and cardiovascular disease prevention the need for a paradigm shift. J Am Coll Cardiol. 2007 Jul 3;50(1):22-4. doi: 10.1016/j.jacc.2007.04.027. Epub 2007 Jun 18. No abstract available.

Reference Type BACKGROUND
PMID: 17601540 (View on PubMed)

Hu FB. Plant-based foods and prevention of cardiovascular disease: an overview. Am J Clin Nutr. 2003 Sep;78(3 Suppl):544S-551S. doi: 10.1093/ajcn/78.3.544S.

Reference Type BACKGROUND
PMID: 12936948 (View on PubMed)

Jenkins DJ, Wolever TM, Ocana AM, Vuksan V, Cunnane SC, Jenkins M, Wong GS, Singer W, Bloom SR, Blendis LM, et al. Metabolic effects of reducing rate of glucose ingestion by single bolus versus continuous sipping. Diabetes. 1990 Jul;39(7):775-81. doi: 10.2337/diab.39.7.775.

Reference Type BACKGROUND
PMID: 2191884 (View on PubMed)

Katcher HI, Legro RS, Kunselman AR, Gillies PJ, Demers LM, Bagshaw DM, Kris-Etherton PM. The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. Am J Clin Nutr. 2008 Jan;87(1):79-90. doi: 10.1093/ajcn/87.1.79.

Reference Type BACKGROUND
PMID: 18175740 (View on PubMed)

Kromhout D, Menotti A, Kesteloot H, Sans S. Prevention of coronary heart disease by diet and lifestyle: evidence from prospective cross-cultural, cohort, and intervention studies. Circulation. 2002 Feb 19;105(7):893-8. doi: 10.1161/hc0702.103728. No abstract available.

Reference Type BACKGROUND
PMID: 11854133 (View on PubMed)

McCaffrey TA, Rennie KL, Kerr MA, Wallace JM, Hannon-Fletcher MP, Coward WA, Jebb SA, Livingstone MB. Energy density of the diet and change in body fatness from childhood to adolescence; is there a relation? Am J Clin Nutr. 2008 May;87(5):1230-7. doi: 10.1093/ajcn/87.5.1230.

Reference Type BACKGROUND
PMID: 18469244 (View on PubMed)

Newby PK, Muller D, Hallfrisch J, Qiao N, Andres R, Tucker KL. Dietary patterns and changes in body mass index and waist circumference in adults. Am J Clin Nutr. 2003 Jun;77(6):1417-25. doi: 10.1093/ajcn/77.6.1417.

Reference Type BACKGROUND
PMID: 12791618 (View on PubMed)

Olaiz-Fernández, G., Rivera-Dommarco, J., Shamah-Levy, T., Rojas, R., Villalpando-Hernández, S., Hernández-Avila, M. & Sepúlveda, J. (2006) Encuesta Nacional de Salud y Nutrición. Cuernavaca, México: Instituto Nacional de Salud Pública. Available at: http://www.insp.mx/images/stories/ENSANUT/Docs/Ensanut2006.pdf (Accessed on June 2011)

Reference Type BACKGROUND

Pan Y, Pratt CA. Metabolic syndrome and its association with diet and physical activity in US adolescents. J Am Diet Assoc. 2008 Feb;108(2):276-86; discussion 286. doi: 10.1016/j.jada.2007.10.049.

Reference Type BACKGROUND
PMID: 18237576 (View on PubMed)

Rakel: Integrative Medicine, 2nd ed. Saunders, Elsevier, 2007.

Reference Type BACKGROUND

Roberts CK, Liu S. Carbohydrate intake and obesity: an association that needs "refining". J Am Diet Assoc. 2009 Jul;109(7):1163-4. doi: 10.1016/j.jada.2009.04.016. No abstract available.

Reference Type BACKGROUND
PMID: 19559131 (View on PubMed)

Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr. 2010 Mar;91(3):502-9. doi: 10.3945/ajcn.2008.26285. Epub 2010 Jan 20.

Reference Type BACKGROUND
PMID: 20089734 (View on PubMed)

Steffen LM, Jacobs DR Jr, Murtaugh MA, Moran A, Steinberger J, Hong CP, Sinaiko AR. Whole grain intake is associated with lower body mass and greater insulin sensitivity among adolescents. Am J Epidemiol. 2003 Aug 1;158(3):243-50. doi: 10.1093/aje/kwg146.

Reference Type BACKGROUND
PMID: 12882946 (View on PubMed)

Steffen LM, Jacobs DR Jr, Stevens J, Shahar E, Carithers T, Folsom AR. Associations of whole-grain, refined-grain, and fruit and vegetable consumption with risks of all-cause mortality and incident coronary artery disease and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr. 2003 Sep;78(3):383-90. doi: 10.1093/ajcn/78.3.383.

Reference Type BACKGROUND
PMID: 12936919 (View on PubMed)

Wang Y, Beydoun MA. The obesity epidemic in the United States--gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev. 2007;29:6-28. doi: 10.1093/epirev/mxm007. Epub 2007 May 17.

Reference Type BACKGROUND
PMID: 17510091 (View on PubMed)

Weickert MO, Pfeiffer AF. Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr. 2008 Mar;138(3):439-42. doi: 10.1093/jn/138.3.439.

Reference Type BACKGROUND
PMID: 18287346 (View on PubMed)

Wolever TM, Jenkins DJ, Jenkins AL, Josse RG. The glycemic index: methodology and clinical implications. Am J Clin Nutr. 1991 Nov;54(5):846-54. doi: 10.1093/ajcn/54.5.846.

Reference Type BACKGROUND
PMID: 1951155 (View on PubMed)

Wolever TM, Mehling C. High-carbohydrate-low-glycaemic index dietary advice improves glucose disposition index in subjects with impaired glucose tolerance. Br J Nutr. 2002 May;87(5):477-87. doi: 10.1079/BJNBJN2002568.

Reference Type BACKGROUND
PMID: 12010586 (View on PubMed)

Zehner, L and Zehner W. Mixtures of fructose, sucrose and lactose as a low-calorie bulk sweetener with reduced glycemic index. United States Patent 7560443, 2003.

Reference Type BACKGROUND

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IGPMJP2013-CINCO

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.